See the DrugPatentWatch profile for iclusig
How long can you stay on Iclusig (ponatinib)?
There is no single “maximum time” that applies to everyone. On Iclusig (ponatinib), treatment length is typically determined by how well it controls your leukemia and whether side effects can be managed. In practice, many people stay on Iclusig for as long as it is working and they can tolerate it, but some stop earlier because of progression or safety issues.
What decides whether you keep taking it or stop?
Clinicians usually review continued use based on:
- Response to treatment (for example, whether your leukemia remains controlled)
- Disease status over time (ongoing response vs progression)
- Side effects and safety risks, especially blood vessel and heart-related risks associated with ponatinib
- Lab results and overall health (which can affect dose and whether treatment continues)
If side effects become too serious or if the leukemia is no longer responding, your prescriber may stop Iclusig or switch therapy.
Can Iclusig be continued after remission?
Sometimes, yes. In many cancers treated with targeted therapy, patients may continue treatment even after remission or major response to help prevent relapse, as long as the benefits continue to outweigh the risks. Your prescriber would tailor this to your specific response and side-effect profile.
What if you miss doses or need dose changes?
Keeping treatment on schedule matters, but occasional missed doses and planned dose adjustments are common in real-world care. Your clinician may reduce the dose or interrupt therapy to manage adverse events and then restart if it’s safe.
What should you ask your care team?
Useful questions include:
- “How long do you expect me to stay on Iclusig given my current response?”
- “What specific side effects would make you stop or reduce my dose?”
- “How often will you monitor my response and safety while I’m on it?”
If you tell me your diagnosis (CML vs Ph+ ALL), your current response status (major response vs complete response), and any side effects you’ve had, I can help you understand what usually drives the decision to continue vs stop.